This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Hepatitis C, Chronic
and you are
between 18 and 60
years old
1
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

A Double-Blind, Randomized, Placebo-Controlled, Multiple Dose Ranging Study Evaluating the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of GS-6620 in Treatment Naïve Subjects with Chronic Hepatitis C Virus Infection.

Provided treatments

  • Drug: GS-6620
  • Drug: GS-6620
  • Drug: GS-6620
  • Drug: GS-6620
  • Drug: GS-6620
  • Drug: GS-6620
  • Drug: GS-6620 tablet, 450 mg BID
  • Drug: GS-6620 tablet
  • Drug: GS-6620 tablet

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01316237. The sponsor of the trial is Gilead Sciences and it is looking for 90 volunteers for the current phase.
Official trial title:
A Phase 1 Double-Blind, Randomized, Placebo-Controlled, Multiple Dose Ranging Study Evaluating the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of GS-6620 in Treatment Naïve Subjects With Chronic Hepatitis C Virus Infection